Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 7, 2013 - Issue 5
Submit an article Journal homepage
808
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Oxygen for end-of-life lung cancer care: managing dyspnea and hypoxemia

Brian TiepCity of Hope National Medical Center, Duarte, California, USACorrespondence[email protected]
,
Rick CarterLamar University, Texas, USA
,
Finly ZachariahCity of Hope National Medical Center, Duarte, California, USA
,
Anna C WilliamsCity of Hope National Medical Center, Duarte, California, USA
,
David HorakCity of Hope National Medical Center, Duarte, California, USA
,
Mary BarnettCity of Hope National Medical Center, Duarte, California, USA
&
Rachel DunhamCity of Hope National Medical Center, Duarte, California, USA
 show all
Pages 479-490 | Published online: 09 Jan 2014

References

  • Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann. Intern. Med. 93(3), 391–398 (1980).
  • Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1(8222), 681–686 (1981).
  • Banzett RB, Gracely RH, Lansing RW. When it's hard to breathe, maybe pain doesn't matter. Focus on “Dyspnea as a noxious sensation: inspiratory threshold loading may trigger diffuse noxious inhibitory controls in humans”. J. Neurophysiol. 97(2), 959–960 (2007).
  • Griffin JP, Nelson JE, Koch KA et al.; American College of Chest Physicians. End-of-life care in patients with lung cancer. Chest 123(1 Suppl.), 312S–331S (2003).
  • Maunder RJ. JPM Patient Information. Oxygen therapy at the end of life. J. Palliat. Med. 9(4), 1030–1031 (2006).
  • Dudgeon DJ, Lertzman M, Askew GR. Physiological changes and clinical correlations of dyspnea in cancer outpatients. J. Pain Symptom. Manage 21(5), 373–379 (2001).
  • Abernethy AP, McDonald CF, Frith PA et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 376(9743), 784–793 (2010).
  • Moore RP, Berlowitz DJ, Denehy L et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax 66(1), 32–37 (2011).
  • Currow DC, Agar M, Smith J, Abernethy AP. Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliat. Med. 23(4), 309–316 (2009).
  • Hallenbeck J. Pathophysiologies of dyspnea explained: why might opioids relieve dyspnea and not hasten death? J. Palliat. Med. 15(8), 848–853 (2012).
  • Clemens KE, Klaschik E. Dyspnoea associated with anxiety–symptomatic therapy with opioids in combination with lorazepam and its effect on ventilation in palliative care patients. Support Care Cancer 19(12), 2027–2033 (2011).
  • Reinke LF, Engelberg RA, Shannon SE et al. Transitions regarding palliative and end-of-life care in severe chronic obstructive pulmonary disease or advanced cancer: themes identified by patients, families, and clinicians. J. Palliat. Med. 11(4), 601–609 (2008).
  • Levy, M., Tanios MA, Nelson D et al. Outcomes of patients with do-not-intubate orders treated with noninvasive ventilation. Crit. Care Med. 32(10), 2002–2007 (2004).
  • Davis CL. ABC of palliative care. Breathlessness, cough, and other respiratory problems. BMJ 315(7113), 931–934 (1997).
  • Bruera E, Neumann CM. Management of specific symptom complexes in patients receiving palliative care. CMAJ 158(13), 1717–1726 (1998).
  • Thomas JR, von Gunten CF. Management of dyspnea. J. Support Oncol. 1(1), 23–32 (2003); discussion 32–34.
  • Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest 89(2), 234–236 (1986).
  • Nishino T, Shimoyama N, Ide T, Isono S. Experimental pain augments experimental dyspnea, but not vice versa in human volunteers. Anesthesiology 91(6), 1633–1638 (1999).
  • Williams AC, Grant M, Tiep B, Kim J, Hayter J. Dyspnea management in early-stage lung cancer: a palliative perspective. J. Hospice Palliat. Nursing 14(5), 332–340 (2012).
  • Mahler DA, O'Donnell D. Dyspnea: mechanisms, measurement, and management. In: Lung Biology in Health and Disease (2nd Edition). Taylor & Francis, Boca Raton xvii, 472 (2005).
  • Harver A, Mahler DA, Schwartzstein RM, Baird JC. Descriptors of breathlessness in healthy individuals: distinct and separable constructs. Chest 118(3), 679–690 (2000).
  • Elliott MW. The language of breathlessness. Monaldi Arch. Chest Dis. 53(6), 664–668 (1998).
  • Elliott MW, Adams L, Cockcroft A et al. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am. Rev. Respir. Dis. 144(4), 826–832 (1991).
  • Zebraski SE, Kochenash SM, Raffa RB. Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Life Sci. 66(23), 2221–2231 (2000).
  • Coyne PJ, Viswanathan R, Smith TJ. Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. J. Pain Symptom. Manage. 23(2), 157–160 (2002).
  • Bruera E, Sala R, Spruyt O, Palmer JL, Zhang T, Willey J. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study. J. Pain Symptom. Manage. 29(6), 613–618 (2005).
  • Kallet RH. The role of inhaled opioids and furosemide for the treatment of dyspnea. Respir. Care 52(7), 900–910 (2007).
  • Gauna AA, Kang SK, Triano ML, Swatko ER, Vanston VJ. Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series. J. Palliat. Med. 11(4), 643–648 (2008).
  • Zeppetella G. Dynamics of breakthrough pain vs. pharmacokinetics of oral morphine: implications for management. Eur. J. Cancer Care (Engl.) 18(4), 331–337 (2009).
  • Navigante AH, Castro MA, Cerchietti LC. Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated. J. Pain Symptom Manage. 39(5), 820–830 (2010).
  • Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane. Database Syst. Rev. (1), CD007354 (2010).
  • Kohara H, Ueoka H, Aoe K et al. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. J. Pain Symptom. Manage. 26(4), 962–967 (2003).
  • Currow DC, Ward AM, Abernethy AP. Advances in the pharmacological management of breathlessness. Curr. Opin. Support Palliat. Care 3(2), 103–106 (2009).
  • Viola R, Kiteley C, Lloyd NS et al. The management of dyspnea in cancer patients: a systematic review. Support Care Cancer 16(4), 329–337 (2008).
  • Mercadante S, Porzio G, Valle A et al. Palliative sedation in patients with advanced cancer followed at home: a systematic review. J. Pain Symptom. Manage. 41(4), 754–760 (2011).
  • Galbraith S, Fagan P, Perkins P, Lynch A, Booth S. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J. Pain Symptom. Manage. 39(5), 831–838 (2010).
  • Hodgkin JE, Celli BR, Connors GL. Pulmonary Rehabilitation : Guidelines to Success (4th Edition). Mosby/Elsevier, St. Louis, Mo. xiv, 583 (2009).
  • Tiep BL, Burns M, Kao D, Madison R, Herrera J. Pursed lips breathing training using ear oximetry. Chest 90(2), 218–221 (1986).
  • Ozalevli S, Ilgin D, Kul Karaali H, Bulac S, Akkoclu A. The effect of in-patient chest physiotherapy in lung cancer patients. Support Care Cancer 18(3), 351–358 (2010).
  • Yang IA, Relan V, Wright CM et al. Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets 15(4), 439–456 (2011).
  • Booth S, Wade R. Oxygen or air for palliation of breathlessness in advanced cancer. J. R. Soc. Med. 96(5), 215–218 (2003).
  • Tiep BL. Portable Oxygen Therapy : Including Oxygen Conserving Methodology. Futura Pub. Co., Mount Kisco, NY xvii, 490 (1991).
  • Schwartzstein RM, Lahive K, Pope A, Weinberger SE, Weiss JW. Cold facial stimulation reduces breathlessness induced in normal subjects. Am. Rev. Respir. Dis. 136(1), 58–61 (1987).
  • West GA, Primeau P. Nonmedical hazards of long-term oxygen therapy. Respir. Care 28(7), 906–912 (1983).
  • Donat SM, Levy DA. Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary? J. Urol. 160(4), 1347–1352 (1998).
  • Tiep B, Carter R. Oxygen conserving devices and methodologies. Chron. Respir. Dis. 5(2), 109–114 (2008).
  • Tiep BL, Nicotra B, Carter R, Belman MJ, Mittman C. Evaluation of a low-flow oxygen-conserving nasal cannula. Am. Rev. Respir. Dis. 130(3), 500–502 (1984).
  • Carter R, Wautelet F, Delwiche JP, Prignot J, Dubois P. Evaluation of the pendant oxygen-conserving nasal cannula during exercise. Chest 89(6), 806–810 (1986).
  • Collard P, Wautelet F, Delwiche JP, Prignot J, Dubois P. Improvement of oxygen delivery in severe hypoxaemia by a reservoir cannula. Eur. Respir. J. 2(8), 778–781 (1989).
  • Sheehan CJ, O'Donohue WJ. Use of a reservoir nasal cannula in hospitalized patients with refractory hypoxemia. Chest 110(4), S1 (1996).
  • Tiep B, Murray R, Barnett M, Carter R. Auto-adjusting demand oxygen delivery system that minimizes SaO2 swings between rest and exertion. Chest 126 Abstract(4) (2004).
  • Heimlich HJ, Carr GC. The micro-trach. A seven-year experience with transtracheal oxygen therapy. Chest 95(5), 1008–1012 (1989).
  • Hoffman AM, Viel L. A percutaneous transtracheal catheter system for improved oxygenation in foals with respiratory distress. Equine. Vet. J. 24(3), 239–241 (1992).
  • Wesmiller SW, Hoffman LA, Sciurba FC, Ferson PF, Johnson JT, Dauber JH. Exercise tolerance during nasal cannula and transtracheal oxygen delivery. Am. Rev. Respir. Dis. 141(3), 789–791 (1990).
  • Christopher KL, Schwartz MD. Transtracheal oxygen therapy. Chest 139(2), 435–440 (2011).
  • Tiep BL, Christopher KL, Spofford BT, Goodman JR, Worley PD, Macy SL. Pulsed nasal and transtracheal oxygen delivery. Chest 97(2), 364–368 (1990).
  • Garvey C, Tiep B, Carter R, Barnett M, Hart M, Casaburi R. Severe exercise-induced hypoxemia. Respir. Care 57(7), 1154–1160 (2012).
  • Tiep B, Barnett M. High flow nasal vs high flow mask oxygen delivery: Tracheal gas concentrations through head extension airway model. Respir. Care 47(9), 1079 (2002).
  • Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir. Care 50(5), 604–609 (2005).
  • Rello J, Pérez M, Roca O et al. High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J. Crit. Care 27(5), 434–439 (2012).
  • Peters SG, Holets SR, Gay PC. Nasal high flow oxygen therapy in do-not-intubate patients with hypoxemic respiratory distress. Respir. Care 58(4), 597–600 (2013).
  • Nomori H, Horio H, Suemasu K. Assisted pressure control ventilation via a mini-tracheostomy tube for postoperative respiratory management of lung cancer patients. Respir. Med. 94(3), 214–220 (2000).
  • Dumont CP, Tiep BL. Using a reservoir nasal cannula in acute care. Crit. Care Nurse. 22(4), 41–46 (2002).
  • Chanques G, Constantin JM, Sauter M et al. Discomfort associated with underhumidified high-flow oxygen therapy in critically ill patients. Intensive Care Med. 35(6), 996–1003 (2009).
  • Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive pressure ventilation reverses acute respiratory failure in select “do-not-intubate” patients. Crit. Care Med. 33(9), 1976–1982 (2005).
  • Gay PC, Hess DR, Hill NS. Noninvasive proportional assist ventilation for acute respiratory insufficiency. Comparison with pressure support ventilation. Am. J. Respir. Crit. Care Med. 164(9), 1606–1611 (2001).
  • Hess DR. The mask for noninvasive ventilation: principles of design and effects on aerosol delivery. J. Aerosol. Med. 20( Suppl. 1), S85–S98 (2007); discussion S98–S99.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.